Screener
TransMedics Group, Inc. TMDX EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from TransMedics Group, Inc.’s reported figures.
The source filing: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206453
FAQ
- What is TransMedics Group, Inc.'s EBITDA?
- TransMedics Group, Inc. (TMDX) reported EBITDA of $25.16M in Q1 2026.
- How has TransMedics Group, Inc.'s EBITDA changed year-over-year?
- TransMedics Group, Inc.'s EBITDA decreased by 25.1% year-over-year, from $33.58M to $25.16M.
- What is the long-term trend for TransMedics Group, Inc.'s EBITDA?
- Over 4 years (2021 to 2025), TransMedics Group, Inc.'s EBITDA has grown at a 37.8% compound annual growth rate (CAGR), from -$37.61M to $135.77M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about TransMedics Group, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude